Revenues: | |
Sponsored research and development | |
Milestones and license fees | |
Total revenues | 0 |
Operating expenses: | |
Research and development | 20.94M |
General and administrative | 17.49M |
Cease-use expense | |
Total operating expenses | 38.44M |
Income (loss) from operations | -38.44M |
Other income: | |
Gain on sale/disposal of assets | |
Deferred gain on real estate | 853K |
Investment income and (expense), net | |
Other income, net | |
Total other income | 1.55M |
Net income (loss) | -36.89M |
Net income (loss) per common share: | |
Basic | |
Diluted | |
Shares used in the calculation of net income (loss) per common share: | |
Basic | |
Diluted |